Microfluidic culture models to study the hydrodynamics of tumor progression and therapeutic response

Biotechnology and Bioengineering

Volumn 110, Issue 8, 2013, Pages 2063-2072

  Buchanan, Cara ^a   Rylander, Marissa Nichole ^a,b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b State University   (United States)

Author keywords

3D cell culture; Microfluidics; Tumor engineering

Indexed keywords

3-D CELL CULTURE; FUNDAMENTAL MECHANISMS; HYDRODYNAMIC CONDITIONS; MICROFLUIDIC TECHNOLOGIES; MORPHOLOGICAL CHANGES; SIMULTANEOUS CONTROL; THERAPEUTIC STRATEGY; TUMOR MICROENVIRONMENT;

BIOMIMETICS; CELL CULTURE; FLUID MECHANICS; HYDRODYNAMICS; PHYSIOLOGICAL MODELS; PHYSIOLOGY; SCAFFOLDS (BIOLOGY); THREE DIMENSIONAL; TUMORS;

MICROFLUIDICS;

CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 1; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL CULTURE; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SCREENING; EXTRACELLULAR MATRIX; HIGH THROUGHPUT SCREENING; HYDRAULIC PERMEABILITY; HYDRODYNAMICS; HYDROPHOBICITY; MICROFLUIDICS; MICROTECHNOLOGY; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR WEIGHT; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SHEAR STRESS; STROMA CELL; TISSUE ENGINEERING; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; YOUNG MODULUS;

ANTINEOPLASTIC AGENTS; HYDRODYNAMICS; MICROFLUIDICS; MODELS, BIOLOGICAL; NEOPLASMS; TISSUE ENGINEERING;

EID: 84879603348     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24944     Document Type: Article

References (94)

1. Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez HM, Oyasu M, Mikels A, Vaysberg M, Ghermazien H, Wai C, Garcia CA, Velayo AC, Jorgensen B, Biermann D, Tsai D, Green J, Zaffryar-Eilot S, Holzer A, Ogg S, Thai D, Neufeld G, Van Vlasselaer P, Smith V. 2010. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med 16(9):1009-1017.
2. Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu MW, et al. 2007. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11(1):83-95.
3. Bauer M, Su G, Beebe DJ, Friedl A. 2010. 3D microchannel co-culture: Method and biological validation. Integr Biol (Camb) 2(7-8):371-378.
4. Beebe DJ, Mensing GA, Walker GM. 2002. Physics and applications of microfluidics in biology. Annu Rev Biomed Eng 4:261-286.
5. Boucher Y, Baxter LT, Jain RK. 1990. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: Implications for therapy. Cancer Res 50(15):4478-4484.
6. Brown E, McKee T, diTomaso E, Pluen A, Seed B, Boucher Y, Jain RK. 2003. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat Med 9(6):796-800.
7. Buchanan CF, Voigt EE, Szot CS, Freeman JW, Vlachos PP, Rylander MN. 2013. 3D microfluidic collagen hydrogels for investigating flow-mediated tumor-endothelial signaling and vascular organization. Tissue Eng Part C Methods (In Press).
8. Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, Yoon CJ, Tims DT, Wang JX, Cheng L, Mohanan S, et al. 2012. Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proc Natl Acad Sci USA 109(25):9786-9791.
9. Chary SR, Jain RK. 1989. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc Natl Acad Sci USA 86(14):5385-5389.
10. Chaw KC, Manimaran M, Tay EH, Swaminathan S. 2007. Multi-step microfluidic device for studying cancer metastasis. Lab Chip 7(8):1041-1047.
11. Chen MC, Gupta M, Cheung KC. 2010. Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening. Biomed Microdevices 12(4):647-654.
12. Cheng SY, Heilman S, Wasserman M, Archer S, Shuler ML, Wu MM. 2007. A hydrogel-based microfluidic device for the studies of directed cell migration. Lab Chip 7(6):763-769.
13. Cheung YK, Azeloglu EU, Shiovitz DA, Costa KD, Seliktar D, Sia SK. 2009. Microscale control of stiffness in a cell-adhesive substrate using microfluidics-based lithography. Angew Chem Int Ed Engl 48(39):7188-7192.
14. Chicurel M. 2002. Cell biology. Cell migration research is on the move. Science 295(5555):606-609.
15. Choi NW, Cabodi M, Held B, Gleghorn JP, Bonassar LJ, Stroock AD. 2007. Microfluidic scaffolds for tissue engineering. Nat Mater 6(11):908-915.
16. Chrobak KM, Potter DR, Tien J. 2006. Formation of perfused, functional microvascular tubes in vitro. Microvasc Res 71(3):185-196.
17. Chung BG, Flanagan LA, Rhee SW, Schwartz PH, Lee AP, Monuki ES, Jeon NL. 2005. Human neural stem cell growth and differentiation in a gradient-generating microfluidic device. Lab Chip 5(4):401-406.
18. Chung S, Sudo R, Mack PJ, Wan CR, Vickerman V, Kamm RD. 2009. Cell migration into scaffolds under co-culture conditions in a microfluidic platform. Lab Chip 9(2):269-275.
19. Chung S, Sudo R, Vickerman V, Zervantonakis IK, Kamm RD. 2010. Microfluidic platforms for studies of angiogenesis, cell migration, and cell-cell interactions. Sixth International Bio-Fluid Mechanics Symposium and Workshop March 28-30, 2008, Pasadena, California. Ann Biomed Eng 38(3):1164-1177.
20. Cross VL, Zheng Y, Choi NW, Verbridge SS, Sutermaster BA, Bonassar LJ, Fischbach C, Stroock AD. 2010. Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. Biomaterials 31(33):8596-8607.
21. Dewey CF Jr, Bussolari SR, Gimbrone MA Jr, Davies PF. 1981. The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng 103(3):177-185.
22. Domachuk P, Tsioris K, Omenetto FG, Kaplan DL. 2009. Bio-microfluidics: Biomaterials and biomimetic designs. Adv Mater 22(2):249-260.
23. Duffy DC, McDonald JC, Schueller OJ, Whitesides GM. 1998. Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal Chem 70(23):4974-4984.
24. Esch MB, King TL, Shuler ML. 2011. The role of body-on-a-chip devices in drug and toxicity studies. Annu Rev Biomed Eng 13:55-72.
25. Farahat WA, Wood LB, Zervantonakis IK, Schor A, Ong S, Neal D, Kamm RD, Asada HH. 2012. Ensemble analysis of angiogenic growth in three-dimensional microfluidic cell cultures. PLoS ONE 7(5):e37333.
26. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ, Mooney DJ. 2007. Engineering tumors with 3D scaffolds. Nat Methods 4(10):855-860.
27. Flessner MF, Choi J, Credit K, Deverkadra R, Henderson K. 2005. Resistance of tumor interstitial pressure to the penetration of intraperitoneally delivered antibodies into metastatic ovarian tumors. Clin Cancer Res 11(8):3117-3125.
28. Freund JB, Goetz JG, Hill KL, Vermot J. 2012. Fluid flows and forces in development: Functions, features and biophysical principles. Development 139(7):1229-1245.
29. Fukumura D, Jain RK. 2007. Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize. J Cell Biochem 101(4):937-949.
30. Fukumura D, Duda DG, Munn LL, Jain RK. 2010. Tumor microvasculature and microenvironment: Novel insights through intravital imaging in pre-clinical models. Microcirculation 17(3):206-225.
31. Grainger SJ, Putnam AJ. 2011. Assessing the permeability of engineered capillary networks in a 3D culture. PLoS ONE 6(7):e22086.
32. Haessler U, Teo JC, Foretay D, Renaud P, Swartz MA. 2012. Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. Integr Biol (Camb) 4(4):401-409.
33. Jain RK. 1999. Understanding barriers to drug delivery: High resolution in vivo imaging is key. Clin Cancer Res 5(7):1605-1606.
34. Jain RK. 2001. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 46(1-3):149-168.
35. Jain RK. 2005. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307(5706):58-62.
36. Jain RK, Stylianopoulos T. 2010. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7(11):653-664.
37. Jain RK, Schlenger K, Hockel M, Yuan F. 1997. Quantitative angiogenesis assays: Progress and problems. Nat Med 3(11):1203-1208.
38. Jain RK, Munn LL, Fukumura D. 2002. Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer 2(4):266-276.
39. Jeon NL, Baskaran H, Dertinger SKW, Whitesides GM, Van de Water L, Toner M. 2002. Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat Biotechnol 20(8):826-830.
40. Jeong GS, Han S, Shin Y, Kwon GH, Kamm RD, Lee SH, Chung S. 2011. Sprouting angiogenesis under a chemical gradient regulated by interactions with an endothelial monolayer in a microfluidic platform. Anal Chem 83(22):8454-8459.
41. Kang L, Chung BG, Langer R, Khademhosseini A. 2008. Microfluidics for drug discovery and development: From target selection to product lifecycle management. Drug Discov Today 13(1-2):1-13.
42. Kim BJ, Wu M. 2012. Microfluidics for mammalian cell chemotaxis. Ann Biomed Eng 40(6):1316-1327.
43. King KR, Wang CCJ, Kaazempur-Mofrad MR, Vacanti JP, Borenstein JT. 2004. Biodegradable microfluidics. Adv Mater 16(22):2007-2012.
44. Lan SF, Starly B. 2011. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities. Toxicol Appl Pharmacol 256(1):62-72.
45. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, et al. 2009. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139(5):891-906.
46. Ling Y, Rubin J, Deng Y, Huang C, Demirci U, Karp JM, Khademhosseini A. 2007. A cell-laden microfluidic hydrogel. Lab Chip 7(6):756-762.
47. Liu T, Li C, Li H, Zeng S, Qin J, Lin B. 2009. A microfluidic device for characterizing the invasion of cancer cells in 3-D matrix. Electrophoresis 30(24):4285-4291.
48. Liu WM, Sun P, Yang LY, Wang JF, Li L, Wang JY. 2010. Assay of glioma cell responses to an anticancer drug in a cell-based microfluidic device. Microfluid Nanofluid 9(4-5):717-725.
49. Mack PJ, Zhang Y, Chung S, Vickerman V, Kamm RD, Garcia-Cardena G. 2009. Biomechanical regulation of endothelium-dependent events critical for adaptive remodeling. J Biol Chem 284(13):8412-8420.
50. Magzoub M, Jin S, Verkman AS. 2008. Enhanced macromolecule diffusion deep in tumors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin. FASEB J 22(1):276-284.
51. Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK. 2000. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 60(9):2497-2503.
52. Ng CP, Pun SH. 2008. A perfusable 3D cell-matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transport. Biotechnol Bioeng 99(6):1490-1501.
53. Ng CP, Helm CL, Swartz MA. 2004. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc Res 68(3):258-264.
54. Ozturk SS. 1996. Engineering challenges in high density cell culture systems. Cytotechnology 22(1-3):3-16.
55. Paguirigan A, Beebe DJ. 2006. Gelatin based microfluidic devices for cell culture. Lab Chip 6(3):407-413.
56. Perentes JY, McKee TD, Ley CD, Mathiew H, Dawson M, Padera TP, Munn LL, Jain RK, Boucher Y. 2009. In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts. Nat Methods 6(2):143-145.
57. Pickl M, Ries CH. 2009. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 28(3):461-468.
58. Polacheck WJ, Charest JL, Kamm RD. 2011. Interstitial flow influences direction of tumor cell migration through competing mechanisms. Proc Natl Acad Sci USA 108(27):11115-11120.
59. Price GM, Tien J. 2011. Methods for forming human microvascular tubes in vitro and measuring their macromolecular permeability. Methods Mol Biol 671:281-293.
60. Price GM, Wong KH, Truslow JG, Leung AD, Acharya C, Tien J. 2010. Effect of mechanical factors on the function of engineered human blood microvessels in microfluidic collagen gels. Biomaterials 31(24):6182-6189.
61. Ramanujan S, Pluen A, McKee TD, Brown EB, Boucher Y, Jain RK. 2002. Diffusion and convection in collagen gels: Implications for transport in the tumor interstitium. Biophys J 83(3):1650-1660.
62. Rutkowski JM, Swartz MA. 2007. A driving force for change: Interstitial flow as a morphoregulator. Trends Cell Biol 17(1):44-50.
63. Saadi W, Rhee SW, Lin F, Vahidi B, Chung BG, Jeon NL. 2007. Generation of stable concentration gradients in 2D and 3D environments using a microfluidic ladder chamber. Biomed Microdevices 9(5):627-635.
64. Sanchez-Freire V, Ebert AD, Kalisky T, Quake SR, Wu JC. 2012. Microfluidic single-cell real-time PCR for comparative analysis of gene expression patterns. Nat Protoc 7(5):829-838.
65. Shao J, Wu L, Wu J, Zheng Y, Zhao H, Lou X, Jin Q, Zhao J. 2010. A microfluidic chip for permeability assays of endothelial monolayer. Biomed Microdevices 12(1):81-88.
66. Shieh AC, Swartz MA. 2011. Regulation of tumor invasion by interstitial fluid flow. Phys Biol 8(1):015012.
67. Shin Y, Jeon JS, Han S, Jung GS, Shin S, Lee SH, Sudo R, Kamm RD, Chung S. 2011. In vitro 3D collective sprouting angiogenesis under orchestrated ANG-1 and VEGF gradients. Lab Chip 11(13):2175-2181.
68. Shin Y, Han S, Jeon JS, Yamamoto K, Zervantonakis IK, Sudo R, Kamm RD, Chung S. 2012. Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels. Nat Protoc 7(7):1247-1259.
69. Sia SK, Whitesides GM. 2003. Microfluidic devices fabricated in poly(dimethylsiloxane) for biological studies. Electrophoresis 24(21):3563-3576.
70. Song JW, Munn LL. 2011. Fluid forces control endothelial sprouting. Proc Natl Acad Sci USA 108(37):15342-15347.
71. Song JW, Cavnar SP, Walker AC, Luker KE, Gupta M, Tung YC, Luker GD, Takayama S. 2009. Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PLoS ONE 4(6):e5756.
72. Song JW, Bazou D, Munn LL. 2012. Anastomosis of endothelial sprouts forms new vessels in a tissue analogue of angiogenesis. Integr Biol (Camb) 4(8):857-862.
73. Squires TM, Quake SR. 2005. Microfluidics: Fluid physics at the nanoliter scale. Rev Mod Phys 77(3):977-1026.
74. Stroock AD, Fischbach C. 2010. Microfluidic culture models of tumor angiogenesis. Tissue Eng Part A 16(7):2143-2146.
75. Stroock AD, Dertinger SK, Ajdari A, Mezic I, Stone HA, Whitesides GM. 2002. Chaotic mixer for microchannels. Science 295(5555):647-651.
76. Sung JH, Shuler ML. 2009. A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip 9(10):1385-1394.
77. Sung JH, Shuler ML. 2012. Microtechnology for mimicking in vivo tissue environment. Ann Biomed Eng 40(6):1289-1300.
78. Sung JH, Kam C, Shuler ML. 2010. A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. Lab Chip 10(4):446-455.
79. Sung KE, Yang N, Pehlke C, Keely PJ, Eliceiri KW, Friedl A, Beebe DJ. 2011. Transition to invasion in breast cancer: A microfluidic in vitro model enables examination of spatial and temporal effects. Integr Biol (Camb) 3(4):439-450.
80. Swartz MA, Lund AW. 2012. Lymphatic and interstitial flow in the tumour microenvironment: Linking mechanobiology with immunity. Nat Rev Cancer 12(3):210-219.
81. Tilghman RW, Cowan CR, Mih JD, Koryakina Y, Gioeli D, Slack-Davis JK, Blackman BR, Tschumperlin DJ, Parsons JT. 2010. Matrix rigidity regulates cancer cell growth and cellular phenotype. PLoS ONE 5(9):e12905.
82. Tredan O, Galmarini CM, Patel K, Tannock IF. 2007. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99(19):1441-1454.
83. Vickerman V, Kamm RD. 2012. Mechanism of a flow-gated angiogenesis switch: Early signaling events at cell-matrix and cell-cell junctions. Integr Biol (Camb) 4(8):863-874.
84. Vickerman V, Blundo J, Chung S, Kamm R. 2008. Design, fabrication and implementation of a novel multi-parameter control microfluidic platform for three-dimensional cell culture and real-time imaging. Lab Chip 8(9):1468-1477.
85. Voigt EE, Buchanan CF, Rylander MN, Vlachos PP. 2012. Wall shear stress measurements in an arterial flow bioreactor. Cardiovasc Eng Technol 3(1):101-111.
86. Walsh CL, Babin BM, Kasinskas RW, Foster JA, McGarry MJ, Forbes NS. 2009. A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeutics. Lab Chip 9(4):545-554.
87. Weaver VM, Lelievre S, Lakins JN, Chrenek MA, Jones JC, Giancotti F, Werb Z, Bissell MJ. 2002. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2(3):205-216.
88. Whitesides GM. 2006. The origins and the future of microfluidics. Nature 442(7101):368-373.
89. Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, et al. 2004. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10(6):649.
90. Wlodkowic D, Cooper JM. 2010. Tumors on chips: Oncology meets microfluidics. Curr Opin Chem Biol 14(5):556-567.
91. Wong KH, Truslow JG, Tien J. 2010. The role of cyclic AMP in normalizing the function of engineered human blood microvessels in microfluidic collagen gels. Biomaterials 31(17):4706-4714.
92. Young EW, Simmons CA. 2010. Macro- and microscale fluid flow systems for endothelial cell biology. Lab Chip 10(2):143-160.
93. Zervantonakis IK, Hughes-Alford SK, Charest JL, Condeelis JS, Gertler FB, Kamm RD. 2012. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc Natl Acad Sci USA 109(34):13515-13520.
94. Zheng Y, Chen J, Craven M, Choi NW, Totorica S, Diaz-Santana A, Kermani P, Hempstead B, Fischbach-Teschl C, Lopez JA, et al. 2012. In vitro microvessels for the study of angiogenesis and thrombosis. Proc Natl Acad Sci USA 109(24):9342-9347.